Growth Metrics

Cullinan Therapeutics (CGEM) Current Taxes (2022 - 2023)

Cullinan Therapeutics has reported Current Taxes over the past 2 years, most recently at $4.2 million for Q1 2023.

  • Quarterly results put Current Taxes at $4.2 million for Q1 2023, changed N/A from a year ago — trailing twelve months through Mar 2023 was $4.2 million (changed N/A YoY), and the annual figure for FY2022 was $4.3 million, changed.
  • Current Taxes for Q1 2023 was $4.2 million at Cullinan Therapeutics, down from $4.3 million in the prior quarter.
  • Over the last five years, Current Taxes for CGEM hit a ceiling of $46.5 million in Q2 2022 and a floor of $4.2 million in Q1 2023.